What to know
- ASML surged 9.5% in a single session — adding tens of billions in market cap — after Musk's Terafab project and Oracle capital flows signaled new demand for its irreplaceable lithography machines.
- ASML is a monopoly — every advanced chipmaker on Earth already waits in line for its equipment.
- A new mega-customer could create a bottleneck that reshapes delivery timelines across the entire chip industry.
There's only one company on the planet that makes a specific tool. Every tech giant — Apple, Nvidia, TSMC, Intel — needs that tool to build their most important products. Now Elon Musk wants to buy a bunch of them too.
That's the situation facing ASML, the Dutch company that makes the insanely complex machines used to manufacture cutting-edge chips. The stock ripped nearly 10% in a single session in early June 2026. But the real story isn't the stock price — it's what happens when the world's most in-demand factory equipment gets one more massive buyer.
Let's walk through the dominoes.
What just happened
ASML, the Dutch semiconductor equipment giant, jumped 9.53% on June 10, 2026, to close at $1,899.48. Trading volume hit 2.93 million shares — about 1.6 times its 20-day average.
The catalyst was a one-two punch. First, Elon Musk joined ASML's annual employee tech conference virtually, as SpaceX prepares for what could be the largest IPO on record. Second, Musk is expected to talk about a chip venture tied to Tesla, SpaceX, and ASML's lithography systems. The industry is calling the project the "Terafab".
On top of that, Oracle is raising cash, and much of it may end up flowing to ASML for equipment purchases. The broader market noticed: the Nasdaq 100 rose 0.53% on June 10.
There's only one company that makes the printing presses for the world's most valuable currency — advanced chips. Musk just placed a massive order.
First domino: Terafab doesn't just add revenue — it adds a decade-long annuity
Every EUV machine ASML ships comes with years of service contracts, spare parts, and software upgrades. These post-sale revenue streams are high-margin and recurring. They lock customers into ASML's ecosystem for a decade or more. When Terafab places an order, it isn't adding a single line item to ASML's backlog — it's adding a multi-year annuity.
ASML raised its 2026 full-year sales guidance to €36–40 billion, up from the €34–39 billion range given earlier. In Q1 alone, the company posted €8.8 billion in net sales and €2.8 billion in net income, with gross margin (revenue minus the direct cost of goods, as a percentage) guided between 51% and 53%.
The market is pricing in conviction — the stock closed near its recent highs on June 10. But ASML's current multiple may not fully reflect the service-annuity value that a project like Terafab would add beyond 2026. That's what makes this more than a one-day pop.
Second domino: The SpaceX IPO becomes a funding engine
SpaceX is preparing to go public in what would be the largest IPO on record. A successful IPO raises billions that could fund Terafab directly. More likely, though, Musk would use his SpaceX shares as collateral to borrow money and fund a separate fab company.
The Terafab explicitly calls for ASML's lithography systems as core infrastructure. The most likely setup: Musk brings outside investors into a dedicated Terafab fund, pointing to SpaceX's post-IPO valuation as proof he's good for the money. This is the same playbook he used to finance Twitter's acquisition — leveraging one asset's value to fund an adjacent venture.
To be clear, no public filing or Musk statement has explicitly earmarked IPO proceeds for chip fab capex. This is inference based on capital structure logic, not a confirmed allocation. But the financial plumbing is there, and the Terafab's equipment requirements point directly at ASML.
Third domino: Take-or-pay contracts could reshape ASML's earnings profile
ASML reported €32.7 billion in total net sales and €9.6 billion in net income for full-year 2025 — a 29% net margin that's impressive for a hardware company. If demand from Terafab and Oracle pushes ASML toward the top end of its €36–40 billion 2026 guidance, earnings growth could outpace revenue growth.
But the non-obvious angle is contract structure. Large fab projects usually require long-term supply deals with take-or-pay terms. That means the buyer commits to purchasing a set number of machines no matter what the market does. If Terafab is set up this way, ASML gets a revenue floor that smooths out earnings swings. That alone could push the stock's valuation higher — even without selling more machines.
At €40 billion in revenue with 53% gross margins, the stock is pricing in a scenario that was considered optimistic six months ago — and it might now be base case.
Fourth domino: The bottleneck tightens for everyone else
ASML is the sole manufacturer of EUV lithography systems. There is a natural production bottleneck — the company can only build so many machines per year. If a Musk-backed Terafab enters the queue, it could delay fab buildouts for existing customers like TSMC, Samsung, and Intel.
This matters beyond ASML's stock price. Chipmakers plan their capacity expansions years in advance. A new mega-buyer fighting for limited machine slots could send shockwaves through the whole chip supply chain. It could delay when new fabs come online and slow how fast AI compute capacity actually grows.
The AI boom that demands more chips may be bottlenecked by the single supplier making the machines to build them.
The very AI boom driving demand for more chips could be slowed down by the fact that there's only one company making the machines to build them.
The last time this happened
The closest structural parallel isn't ASML itself — it's FANUC during Japan's robotics buildout in the 1980s and 1990s. FANUC dominated the market for CNC systems and industrial robots. Then the auto industry showed up as a huge new buyer alongside FANUC's existing electronics customers. Delivery timelines shrank, and FANUC's pricing power surged.
The key question then was the same as now: is the new entrant a volume buyer or a prestige buyer? Automakers turned out to be volume buyers — they needed hundreds of units per factory. That squeezed delivery schedules for existing customers and gave FANUC pricing leverage it had never had before. If Terafab is a volume buyer (a full-scale fab needs dozens of EUV machines), the same dynamic could play out for ASML.
The risk is also instructive. ASML experienced a sharp drawdown in late 2024 after a leaked earnings report showed softer-than-expected bookings. The stock fell roughly 64% from its highs before recovering. Monopoly status doesn't protect against drawdowns — peak-to-trough declines — like that. Momentum stocks punish disappointment harshly, and ASML's elevated multiple leaves little room for a miss.
What could go wrong
The Terafab stays vague. Musk is famous for announcing ambitious projects that take years longer than promised — or never materialize at all. If no binding equipment purchase agreement or confirmed letter of intent appears in ASML's Q3 or Q4 2026 order book disclosures, the Terafab thesis is speculative and the premium should be treated as air.
The SpaceX IPO gets delayed or downsized. If SpaceX's public offering stalls, the capital structure logic connecting it to Terafab funding collapses. No IPO, no collateral, no easy path to financing a multi-billion-dollar fab.
Export controls tighten. ASML already faces restrictions on selling its most advanced machines to China. Further controls — or geopolitical friction involving the Netherlands, U.S., or Musk — could shrink addressable demand.
The bottleneck backfires. If ASML can't scale production fast enough for both existing customers and Terafab, delays could frustrate major clients. That frustration could spark political pressure to subsidize competitors or fund alternative chip-printing methods.
Valuation leaves no margin for error. ASML trades at a premium price tag that bakes in continued demand growth. In a broad market selloff, expensive stocks get hit hardest. ASML's track record shows its drawdowns — peak-to-trough drops — can be steep and fast.
Watchlist
| Ticker | Level | Status | Why |
|---|---|---|---|
| ASML | $1,899.48 (June 10 close) | at recent high | The monopoly supplier at the center of the story. Closed near its highs after a 9.53% single-day surge on June 10, 2026. |
| Confirms: Weekly close above the June 10 high within 2 weeks = breakout confirmedBreaks: Close below $1,700 for 3 consecutive sessions = momentum broken, likely giveback | |||
| TSM | Current | watching | One of ASML's largest customers based on industry analysis. If Terafab competes for machine slots, TSMC's expansion timeline could slip — bad for TSMC, good for ASML's pricing power. |
| Confirms: TSM guidance raises fab timeline estimates at next earnings = bottleneck is realBreaks: TSMC reports accelerated EUV deliveries at Q2 earnings = no bottleneck forming | |||
| NVDA | Current | watching | Nvidia needs TSMC to build its chips, and TSMC needs ASML machines. If the bottleneck tightens, Nvidia's supply could be affected. |
| Confirms: Nvidia mentions fab capacity constraints in Q2 earnings call = domino 4 is playing outBreaks: Nvidia reports no supply issues at Q2 earnings = bottleneck thesis is premature | |||
| ORCL | Current | watching | Oracle is raising cash that may flow to ASML for equipment purchases. A second demand signal beyond Musk. |
| Confirms: Oracle discloses ASML equipment orders in next quarterly filing = capital flow confirmedBreaks: Oracle capital raise directed elsewhere with no ASML mention = one less demand catalyst | |||
Get the weekly digest
One email every Saturday. New stories, new research, no upsell. Unsubscribe with one click.
